IPP Bureau
Henkel launches Packaging RecycLab in China
By IPP Bureau - November 05, 2025
This integrated center combines development, testing, evaluation, and industry-academia-research collaboration
Kulzer reshapes global strategy to drive growth in EMEA and Americas
By IPP Bureau - November 04, 2025
Kulzer has consolidated the production of its core product, artificial teeth, at its facility in Germany
Roche’s Gazyva shows breakthrough efficacy in phase III lupus study
By IPP Bureau - November 04, 2025
The ALLEGORY study demonstrated statistically significant improvements in key measures, including British Isles Lupus Assessment Group-based Composite Lupus Assessment (BICLA) response
Effective corrosion management demands a holistic approach: Experts
By IPP Bureau - November 04, 2025
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Akums Drugs gets 20- year patent for "Dual Release Gastro-Resistant Composition"
By IPP Bureau - November 04, 2025
The company has introduced an innovative Dual Release Proton Pump Inhibitor (PPI) tablet, a next-generation therapy for patients suffering from moderate to severe or treatment resistant gastroesophageal reflux disease
Lilly to build $3 billion oral medicine facility in Netherlands
By IPP Bureau - November 04, 2025
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
Gland Pharma reports Q2 FY26 PAT higher at Rs. 184 Cr
By IPP Bureau - November 04, 2025
Revenue for the quarter rose 5.8% to Rs. 1,487 crore as compared to Rs. 1,406 crore in the corresponding quarter of the previous fiscal
Kimberly-Clark to acquire Kenvue in $48.7 billion mega deal
By IPP Bureau - November 04, 2025
Upon completion, Kimberly-Clark shareholders are expected to own about 54% of the combined entity, while Kenvue shareholders will hold the remaining 46%
.jpg "Cipla to acquire Inzpera Healthsciences for Rs. 110.65 Cr")
Cipla to acquire Inzpera Healthsciences for Rs. 110.65 Cr
By IPP Bureau - November 04, 2025
The transaction is expected to be completed within one month from the signing of the definitive agreements.
Merck Foundation launches $22 million initiative to improve cardiovascular care in US
By IPP Bureau - November 03, 2025
Building on the Merck Foundation’s longstanding commitment to advancing access to high-quality health care, new national initiative supports grants to 11 organizations across the country
Jubilant Pharmova posts consolidated Q2 FY26 PAT at Rs. 120.3 Cr
By IPP Bureau - November 02, 2025
Dr Lal Path Labs reports consolidated Q2 FY26 PAT at Rs. 150.6 Cr
By IPP Bureau - November 02, 2025
The company has posted net profit of Rs. 283 crore for the 6 months period ended September 30, 2025
Cosmo Plastech expands rigid packaging solutions for pharma industry with PET sheets
By IPP Bureau - November 02, 2025
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
Indegene posts consolidated Q2 FY26 PAT at Rs. 102.1 Cr
By IPP Bureau - November 02, 2025
Dr Agarwals Health Care posts consolidated Q2 FY26 PAT at Rs. 29.69 Cr
By IPP Bureau - November 02, 2025
Dr Agarwals Health Care has reported total income of Rs. 506.62 crore during the period ended September 30, 2025
